◆英語タイトル:T2 Biosystems Inc (TTOO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3412
◆発行会社(調査会社):
GlobalData
◆発行日:2018年8月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2Plex for research, T2Plex instrument and T2Lyme panels. T2 Biosystems also offers pipeline products for sepsis management, including bacterial resistance panels, and testing for the superbug Candida auris and a Lyme disease panel. The company’s products provide species-specific identification directly from whole blood. It offers hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians’ offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.
T2 Biosystems Inc (TTOO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
T2 Biosystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
T2 Biosystems Inc, Medical Devices Deals, 2012 to YTD 2018 9
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
T2 Biosystems Raises US$40 Million In Series E Financing 11
Partnerships 13
T2 Biosystems Enters into Agreement with Allergan 13
T2 Biosystems Enters into Co-Development Agreement with Canon U.S. Life Sciences 14
Equity Offering 15
T2 Biosystems Raises USD40 Million in Private Placement of Shares 15
T2 Biosystems Raises USD34 Million in Public Offering of Shares 16
T2 Biosystems Raises USD65.7 Million in IPO 18
T2 Biosystems Inc – Key Competitors 20
T2 Biosystems Inc – Key Employees 21
T2 Biosystems Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 02, 2018: T2 Biosystems reports second quarter 2018 financial results and provides corporate update 23
May 08, 2018: T2 Biosystems Announces First Quarter 2018 Financial Results 24
Mar 06, 2018: T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update 25
Nov 02, 2017: T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update 27
Aug 03, 2017: T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update 29
May 02, 2017: T2 Biosystems Reports First Quarter 2017 Results and Corporate Update 30
Feb 13, 2017: T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results 32
Jan 09, 2017: T2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress 34
Corporate Communications 35
May 01, 2017: T2 Biosystems Names Darlene Deptula-Hicks as Chief Financial Officer 35
Government and Public Interest 36
Mar 06, 2018: T2 Biosystems Awarded Up To $2 Million by CARB-X to Support Development of New Tests on the T2Dx Instrument for Drug-Resistant Bacteria 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Tables
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
T2 Biosystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
T2 Biosystems Inc, Deals By Therapy Area, 2012 to YTD 2018 8
T2 Biosystems Inc, Medical Devices Deals, 2012 to YTD 2018 9
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
T2 Biosystems Raises US$40 Million In Series E Financing 11
T2 Biosystems Enters into Agreement with Allergan 13
T2 Biosystems Enters into Co-Development Agreement with Canon U.S. Life Sciences 14
T2 Biosystems Raises USD40 Million in Private Placement of Shares 15
T2 Biosystems Raises USD34 Million in Public Offering of Shares 16
T2 Biosystems Raises USD65.7 Million in IPO 18
T2 Biosystems Inc, Key Competitors 20
T2 Biosystems Inc, Key Employees 21
T2 Biosystems Inc, Other Locations 22
List of Figures
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
T2 Biosystems Inc, Medical Devices Deals, 2012 to YTD 2018 9